- Presentations
- 3
- Markets
- 1
Qelbree is a brand of Viloxazine marketed by Supernus Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Viloxazine
- Brand owner
- Supernus Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 mg extended-release capsule, 150 mg extended-release capsule, 200 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Qelbree 100 mg extended-release capsuleOral | Supernus Pharmaceuticals | US FDA | Available on request |
| Qelbree 150 mg extended-release capsuleOral | Supernus Pharmaceuticals | US FDA | Available on request |
| Qelbree 200 mg extended-release capsuleOral | Supernus Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Qelbree
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.